Litcius/Paper detail

Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group

Nicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, Markus Ditschkowski, Nico Gagelmann, Martin Grießhammer, Vikas Gupta, Nada Hamad, Claire Harrison, Juan Carlos Hernández‐Boluda, Steffen Koschmieder, Tania Jain, John Mascarenhas, Ruben A. Mesa, Uday Popat, Francesco Passamonti, Nicola Polverelli, Alessandro Rambaldi, Marie Robin, Rachel B. Salit, Thomas Schroeder, Bart L. Scott, Roni Tamari, Ayalew Tefferi, Alessandro M. Vannucchi, Donal P. McLornan, Giovanni Barosi

2023The Lancet Haematology96 citationsDOI

Topics & Concepts

MedicineMyelofibrosisInternational Prognostic Scoring SystemTransplantationHematopoietic stem cell transplantationInternal medicineDiseaseOncologyIntensive care medicineBone marrowMyelodysplastic syndromesMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group | Litcius